Epilepsy is one of the most common neurologic diseases and affects over 70 million people worldwide [1]. The estimated global burden of epilepsy accounts for 5% of the total neurological disability-adjusted life years (DALYs) [2]. Not only is the quality of life lessened in patients with epilepsy, but they also have a higher risk (three times or greater) of dying from sudden cardiac death compared to the general population [3]. The standardized mortality rate in epilepsy patients in high-income countries ranges from 1.6 to 3.0 compared to the general population [4].
18
DIC
DIC
0